glp 1 parkinson's disease Neuroprotective Actions of Glucagon-Like Peptide-1 (GLP-1) Analogues in Alzheimer's and Diseases | CNS Drugs Glucagon-like peptide-1 (GLP-1) receptor agonists

It is well known that HF treatment targeting the neurohumoral triad has almost no impact on the prognosis of patients with HFpEF

Mittag-Roussou V, Wagenpfeil S, Lammert F, Stokes CS

Steele, R., Wall, J

Recalls & Warnings June 13, 2022 Natural and OTC Mole, Skin Tag Removal Products Can Be Dangerous, Warns FDA On June 9, 2022, the FDA warned consumers not to use natural or over-the-counter (OTC) products promoted to treat or remove moles, skin tags, and seborrheic keratoses because they can contain potentially dangerous concentrations of salicylic acid or other harmful ingredients

The product is not approved for the treatment of any medical condition, including obesity or weight management

Thus, novel therapeutic approaches are highly demanded